The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Eribulin mesylate versus eribulin plus anlotinib in patients with advanced or metastatic breast cancer: Results of a phase II study.
 
Liping Liu
No Relationships to Disclose
 
Zhe-Yu Hu
No Relationships to Disclose
 
Ning Xie
No Relationships to Disclose
 
Xiaohong Yang
No Relationships to Disclose
 
Huawu Xiao
No Relationships to Disclose
 
Jing Li
No Relationships to Disclose
 
Can Tian
No Relationships to Disclose
 
Hui Wu
No Relationships to Disclose
 
Jun Lu
No Relationships to Disclose
 
Jianxiang Gao
No Relationships to Disclose
 
Xuming Hu
No Relationships to Disclose
 
Min Cao
No Relationships to Disclose
 
Zhengrong Shui
No Relationships to Disclose
 
Bingliang Liu
No Relationships to Disclose
 
Quchang Ouyang
No Relationships to Disclose